SERA
Sera Prognostics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 4
Ample Liquidity
Negative Gross Margin
Significant Revenue Decline
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SERA
Sera Prognostics, Inc.
A provider of biomarker tests for predicting preterm birth risk
Healthcare Providers and Services
01/17/2008
07/15/2021
NASDAQ Stock Exchange
63
12-31
Common stock
2749 East Parleys Way, Suite 200, Salt Lake City, UT 84109
--
Sera Prognostics, Inc., was incorporated under the laws of the State of Delaware on January 17, 2008. The Company is a women's health diagnostic company that utilizes the Company's proprietary proteomics and bioinformatics platforms to discover, develop and commercialize biomarker tests with clinical significance and economic impact, with the Company's initial focus on improving pregnancy outcomes. The company's vision is to provide critical and actionable information to pregnant women, physicians and healthcare payers to significantly improve maternal and newborn health and significantly reduce healthcare costs.
Earnings Call
Q1/2025
Estimate EPS-0.21
Actual EPS-0.2
Estimate Revenue60.00K
Actual Revenue38.00K
Sera Prognostics Q1 2025: Unpacking Contradictions in Reimbursement Stability, Market Strategy, and Product Launches
May 09,2025 03:38
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.24
Actual EPS-0.16
Estimate Revenue50.00K
Actual Revenue17.00K
Sera Prognostics' Q2 2025: Key Contradictions Unveiled in Reimbursement Strategies and Market Expansion Plans
Aug 07,2025 04:48
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SERA has released its 2025 Q3 earnings. EPS was reported at -0.16, versus the expected -0.21, beating expectations. The chart below visualizes how SERA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SERA has released its 2025 Q3 earnings report, with revenue of 16.00K, reflecting a YoY change of -44.83%, and net profit of -7.81M, showing a YoY change of 1.33%. The Sankey diagram below clearly presents SERA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
